NRX Pharmaceuticals (NRXP)

• Market cap: $179M
• 1 day: 1.95%
• 5 days: 7.44%
• 1 month: 11.44%
• 3 months: 88.74%
• 6 months: 88.74%
• Year to date: 59.92%
• 1 year: 28.13%
• 5 years: -95.66%
• 10 years: -95.64%
• Sector: Healthcare
• Industry: Biotechnology

About: NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Employees: 29